Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 7—July 2022

Multisystem Inflammatory Syndrome after Breakthrough SARS-CoV-2 Infection in 2 Immunized Adolescents, United States

Lyndsey D. Cole, Molly Slate, Samantha Minneman, and Michael J. BozzellaComments to Author 
Author affiliation: University of Colorado, Aurora, Colorado, USA

Main Article

Table 2

Infectious laboratory results for 2 adolescents after multisystem inflammatory syndrome in children symptom onset and throughout hospitalization, United States*

Laboratory test Case-patient 1 Case-patient 2
SARS-CoV-2 spike IgG Positive NA
SARS-CoV-2 nucleocapsid IgG Positive Positive
SARS-CoV-2 PCR Negative Positive†
Other respiratory pathogen panel PCR Negative Negative
Blood culture, peripheral, 2 sets Negative Negative
Urine culture Negative Negative
Epstein Barr virus ab panel Consistent with prior infection Negative
Gastrointestinal pathogen panel PCR Negative NA
Group A Streptococcus throat PCR Negative NA
Quantiferon tuberculosis gold Negative NA
HIV Ag/Ab, 4th-generation NA Nonreactive
Rapid plasma regain NA Nonreactive
Parvovirus IgM and IgG NA Negative
Anti-streptolysin-O NA Negative
Anti-deoxyribonuclease B NA Negative

*Ag, antigen; Ab, antibody. †Case-patient 2 had a positive SARS-CoV-2 PCR result on day-of-illness 11, followed by a negative result on day-of-illness 19.

Main Article

Page created: May 04, 2022
Page updated: June 18, 2022
Page reviewed: June 18, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.